Aukera Therapeutics
About:
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
Top Investors: Venture Kick, BaseLaunch
Description:
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.
Total Funding Amount:
650000 CHF
Headquarters Location:
Basel, Basel-Stadt, Switzerland
Founded Date:
2021-01-01
Founders:
Driton Liko, Stefan Imseng
Number of Employees:
1-10
Last Funding Date:
2022-10-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai